Chemokines and Their Receptors in Islet Allograft Rejection and as Targets for Tolerance Induction
Authors:
Open Access
- 1 April 2006
- journal article
- Published by SAGE Publications in Cell Transplantation
- Vol. 15 (4) , 295-309
Abstract
Graft rejection is a major barrier to successful outcome of transplantation surgery. Islet transplantation introduces insulin secreting tissue into type 1 diabetes mellitus recipients, relieving patients from exogenous insulin injection. However, insulitis of grafted tissue and allograft rejection prevent long-term insulin independence. Leukocyte trafficking is necessary for the launch of successful immune responses to pathogen or allograft. Chemokines, small chemotactic cytokines, direct the migration of leukocytes through their interaction with chemokine receptors found on cell surfaces of immune cells. Unique receptor expression of leukocytes, and the specificity of chemokine secretion during various states of immune response, suggest that the extracellular chemokine milieu specifically homes certain leukocyte subsets. Thus, only those leukocytes required for the current immune task are attracted to the inflammatory site. Chemokine blockade, using antagonists and monoclonal antibodies directed against chemokine receptors, is an emerging and specific immunosuppressive strategy. Importantly, chemokine blockade may potentiate tolerance induction regimens to be used following transplantation surgery, and prevent the need for life-long immunosuppression of islet transplant recipients. Here, the role for chemokine blockade in islet transplant rejection and tolerance is reviewed.Keywords
This publication has 113 references indexed in Scilit:
- Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation1Transplantation, 2003
- CD4+CD25+ regulatory T cells mediate acquired transplant toleranceTransplant Immunology, 2003
- Pharmacologic, biologic, and genetic engineering approaches to potentiation of donorderived dendritic cell tolerogenicity1Transplantation, 2003
- Structure-Function Relationship between the Human Chemokine Receptor CXCR3 and Its LigandsJournal of Biological Chemistry, 2003
- Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation centerTransplantation, 2002
- Interleukin-8 Secretion fromMycobacterium tuberculosis-Infected Monocytes Is Regulated by Protein Tyrosine Kinases but Not by ERK1/2 or p38 Mitogen-Activated Protein KinasesInfection and Immunity, 2002
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- The Role of Chemokine Receptors in Primary, Effector, and Memory Immune ResponsesAnnual Review of Immunology, 2000
- Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migrationEuropean Journal of Immunology, 1997
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997